As an ATP-dependent process, it requires a high intensity of glucose metabolism in tumor cells, and alongside the previously described upregulation of Hif-1α and Pdgfra its expression increasing is evidence of the potentially high chemotherapy resistance of GBM 101.8. The gene discussed is PDGFRA; the disease is neoplasm.